UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: MorfinAlt-20mg-Tablet-SE-BS-MPD-BBDL

Morfin Alternova 20 mg tablett

MPID: SE-100001659-00049754
EURDID: 10549

Full name: Morfin Alternova 20 mg tablett

- Scientific name part: Morfin Alternova

- Strength part: 20 mg

- Pharmaceutical dose form part: Tablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Tablet

Legal status of supply: Medicinal product subject to special medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097139 morphine

Marketing Authorisation 1 of 1

Authorisation number: 49754

Region: Kingdom of Sweden

Marketing authorisation holder: Alternova A/S

Identifier:

  • LOC-100001100

Status: Valid (2014-06-19)

Package 1 of 2

PCID:

Description:
Blister, 100 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 100 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 4 Blister (Aluminium)

Containing: 25 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Morphine hydrochloride

Presentation strength: 20 milligram(s) / 1 tablet

Reference strength:
Morphine 15.19 milligram(s) / 1 tablet

Package 2 of 2

PCID:

Description:
Blister, 25 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 25 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 1 Blister (Aluminium)

Containing: 25 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Morphine hydrochloride

Presentation strength: 20 milligram(s) / 1 tablet

Reference strength:
Morphine 15.19 milligram(s) / 1 tablet

Administrable Product (1 of 1)

Dose form: Tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Morphine hydrochloride

Presentation strength: 20 milligram(s) / 1 tablet

Reference strength:
Morphine 15.19 milligram(s) / 1 tablet